135 related articles for article (PubMed ID: 36825561)
1. Quality performance indicator compliance for the treatment of gastric adenocarcinoma.
Wang Y; Kulasegaran S; Srinivasa S; Koea J; MacCormick A
ANZ J Surg; 2023 May; 93(5):1294-1299. PubMed ID: 36825561
[TBL] [Abstract][Full Text] [Related]
2. Quality performance indicators for the surgical treatment of gastric adenocarcinoma: a systematic review.
Kulasegaran S; Woodhouse B; MacCormick AD; Srinivasa S; Koea J
ANZ J Surg; 2022 Sep; 92(9):1995-2002. PubMed ID: 35238137
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
[TBL] [Abstract][Full Text] [Related]
4. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
[TBL] [Abstract][Full Text] [Related]
5. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
6. Integrated cancer networks improve compliance with national guidelines and outcomes for resectable gastric cancer.
Thiels CA; Hanson KT; Habermann EB; Boughey JC; Grotz TE
Cancer; 2020 Mar; 126(6):1283-1294. PubMed ID: 31821545
[TBL] [Abstract][Full Text] [Related]
7. Extent of gastrectomy and lymphadenectomy for gastric adenocarcinoma.
Hu Y; Yoon SS
Surg Oncol; 2022 Mar; 40():101689. PubMed ID: 34839198
[TBL] [Abstract][Full Text] [Related]
8. Modern surgical considerations for gastric cancer.
Ly QP; Sasson AR
J Natl Compr Canc Netw; 2008 Oct; 6(9):885-94. PubMed ID: 18926098
[TBL] [Abstract][Full Text] [Related]
9. Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial.
Claassen YHM; van Sandick JW; Hartgrink HH; Dikken JL; De Steur WO; van Grieken NCT; Boot H; Cats A; Trip AK; Jansen EPM; Meershoek-Klein Kranenbarg WM; Braak JPBM; Putter H; van Berge Henegouwen MI; Verheij M; van de Velde CJH
Br J Surg; 2018 May; 105(6):728-735. PubMed ID: 29652082
[TBL] [Abstract][Full Text] [Related]
10. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States.
Tee MC; Pirozzi N; Brahmbhatt RD; Raman S; Franko J
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1941-1947. PubMed ID: 32466860
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary experience of dual-port laparoscopic distal gastrectomy for gastric cancer].
Lin T; Yu J; Hu Y; Liu H; Lu Y; Zhao M; Chen H; Chen X; Li G
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):35-42. PubMed ID: 30703792
[TBL] [Abstract][Full Text] [Related]
13. Rationale for the current surgical management of gastric adenocarcinoma.
Dalton RR; Eisenberg BL
Oncology (Williston Park); 1994 Jul; 8(7):99-105; discussion 105-7. PubMed ID: 7917844
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of gastric adenocarcinoma. Official expert recommendations delivered under the aegis of the French Association of Surgery (AFC).
Voron T; Romain B; Bergeat D; Véziant J; Gagnière J; Le Roy B; Pasquer A; Eveno C; Gaujoux S; Pezet D; Gronnier C; ;
J Visc Surg; 2020 Apr; 157(2):117-126. PubMed ID: 32151595
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: Utilization and short-term oncologic outcomes.
Ecker BL; Datta J; McMillan MT; Poe SL; Drebin JA; Fraker DL; Dempsey DT; Karakousis GC; Roses RE
J Surg Oncol; 2015 Nov; 112(6):616-21. PubMed ID: 26394810
[TBL] [Abstract][Full Text] [Related]
16. Incorporating surgical quality into the AJCC 7th edition improves staging accuracy in gastric cancer.
Deutsch GB; O'Connor V; Sim MS; Lee JH; Bilchik AJ
Ann Surg Oncol; 2015 Jan; 22(1):11-6. PubMed ID: 25192676
[TBL] [Abstract][Full Text] [Related]
17. Staging and surgical approaches in gastric cancer: A systematic review.
Coburn N; Cosby R; Klein L; Knight G; Malthaner R; Mamazza J; Mercer CD; Ringash J
Cancer Treat Rev; 2018 Feb; 63():104-115. PubMed ID: 29275224
[TBL] [Abstract][Full Text] [Related]
18. D2 lymph node dissection improves staging in patients with gastric adenocarcinoma.
Putchakayala K; Difronzo LA
Am Surg; 2011 Oct; 77(10):1326-9. PubMed ID: 22127080
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
Volpe CM; Driscoll DL; Douglass HO
Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
[TBL] [Abstract][Full Text] [Related]
20. A real-life analysis on the indications and prognostic relevance of perioperative chemotherapy in locally advanced resectable gastric adenocarcinoma.
Pardo F; Osorio J; Miranda C; Castro S; Miró M; Luna A; Garsot E; Momblán D; Galofré G; Rodríguez-Santiago J; Pera M;
Clin Transl Oncol; 2020 Aug; 22(8):1335-1344. PubMed ID: 31865605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
